183 related articles for article (PubMed ID: 9844346)
1. [Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].
Kondo A; Oketani N; Maruyama M; Taguchi Y; Yamaguchi Y; Miyao H; Mashima I; Oono M; Wada K; Tsuchiya T; Takahashi H; Abe S
Kekkaku; 1998 Oct; 73(10):585-90. PubMed ID: 9844346
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
3. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia].
Honda Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():181-5. PubMed ID: 9216212
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of levels of lung surfactant protein A in serum, in various lung diseases].
Abe S; Honda Y; Ando M; Saita N; Kida K; Jinno S; Kondo A; Kuroki Y; Akino T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1219-25. PubMed ID: 8583713
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis.
Kuroki Y; Tsutahara S; Shijubo N; Takahashi H; Shiratori M; Hattori A; Honda Y; Abe S; Akino T
Am Rev Respir Dis; 1993 Mar; 147(3):723-9. PubMed ID: 8442609
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.
Honda Y; Kuroki Y; Matsuura E; Nagae H; Takahashi H; Akino T; Abe S
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1860-6. PubMed ID: 8520747
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS.
Endo S; Sato N; Nakae H; Yamada Y; Makabe H; Abe H; Imai S; Wakabayashi G; Inada K; Sato S
Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):245-51. PubMed ID: 15244040
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
Küpeli E; Karnak D; Beder S; Kayacan O; Tutkak H
Respiration; 2008; 75(1):73-8. PubMed ID: 17975298
[TBL] [Abstract][Full Text] [Related]
10. [The examinations for diffuse lung diseases].
Otake K; Suwabe A; Tominaga M
Rinsho Byori; 2000 Dec; 48(12):1112-7. PubMed ID: 11215419
[TBL] [Abstract][Full Text] [Related]
11. [Surfactant proteins A and D as biomarkers of disease activity in diffuse interstitial pneumonia].
Abe S; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2000 Mar; 38(3):157-65. PubMed ID: 10846395
[TBL] [Abstract][Full Text] [Related]
12. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages.
Ferguson JS; Voelker DR; McCormack FX; Schlesinger LS
J Immunol; 1999 Jul; 163(1):312-21. PubMed ID: 10384130
[TBL] [Abstract][Full Text] [Related]
17. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.
Ohnishi H; Yokoyama A; Kondo K; Hamada H; Abe M; Nishimura K; Hiwada K; Kohno N
Am J Respir Crit Care Med; 2002 Feb; 165(3):378-81. PubMed ID: 11818324
[TBL] [Abstract][Full Text] [Related]
19. [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
Nakamura M; Ogura T; Miyazawa N; Tagawa A; Kozawa S; Watanuki Y; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):455-9. PubMed ID: 17644940
[TBL] [Abstract][Full Text] [Related]
20. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
